Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201)

Y-K Kang; H-M Chang; J H Yook; M-H Ryu; I Park; Y J Min; D Y Zang; G Y Kim; D H Yang; S J Jang; Y S Park; J-L Lee; T W Kim; S T Oh; B K Park; H-Y Jung; B S Kim

首页> 外文期刊>British Journal of Cancer >Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201)

【24h】

Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201)

机译：胃癌的辅助化疗：根治性D2胃切除术后丝裂霉素C联合短期多西氟哌啶或长期多西氟哌啶联合顺铂的3期随机试验（AMC0201）

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background:This phase 3 study evaluated the efficacy of new adjuvant chemotherapy (MFP), which intensified the mitomycin-C (MMC) plus short-term doxifluridine (Mf) for gastric cancer.

机译：背景：这项3期研究评估了新辅助化疗（MFP）的疗效，该化疗增强了丝裂霉素C（MMC）联合短期多西氟替丁（Mf）的胃癌治疗。

著录项

来源
《British Journal of Cancer》 |2013年第6期|共7页
作者
Y-K Kang; H-M Chang; J H Yook; M-H Ryu; I Park; Y J Min; D Y Zang; G Y Kim; D H Yang; S J Jang; Y S Park; J-L Lee; T W Kim; S T Oh; B K Park; H-Y Jung; B S Kim;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献

1. Survival results of a randomised two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of S-1 plus cisplatin (SC) and paclitaxel plus cisplatin (PC) followed by D2 gastrectomy for resectable advanced gastric cancer [J] . Yoshikawa Takaki, Morita Satoshi, Tanabe Kazuaki, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2016,第Null期

机译：比较新辅助化疗与两至四个疗程的S-1加顺铂（SC）和紫杉醇加顺铂（PC）联合D2胃切除术治疗可切除的晚期胃癌的随机二乘二因子II期试验的生存结果
2. Three-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy [J] . FujitaniK., TamuraS., KimuraY., Gastric cancer: official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association . 2014,第2期

机译：治愈性D2胃切除术后S-1加多西紫杉醇辅助治疗III期胃癌的II期临床研究的三年结果
3. Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial [J] . NohS.H., ParkS.R., YangH.-K., The lancet oncology . 2014,第12期

机译：辅助卡培他滨联合奥沙利铂治疗D2胃切除术后胃癌（CLASSIC）：一项开放标签，随机3期试验的5年随访
4. A Successfully Treated Case of Stage IV Gastric Cancer with Outlet Stenosis Undergoing Curative Gastrectomy After Preoperative S-1 Plus Cisplatin Following Laparoscopic Assisted Gastrectomy. [C] . Y.Okumura, Y.Iwasaki, M.Ohashi, International Gastric Cancer Congress . 2009

机译：腹腔镜辅助胃切除术后，在术前S-1加顺铂术后成功处理了阶段IV胃癌的阶段胃癌。
5. Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201) [O] . Y-K Kang, H-M Chang, J H Yook, 2013

机译：胃癌的辅助化疗：根治性D2胃切除术后丝裂霉素C联合短期多西氟哌啶或长期多西氟哌啶联合顺铂的3期随机试验（AMC0201）
6. Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201) [O] . Y-K Kang, H-M Chang, J H Yook, 2013

机译：胃癌的辅助化疗：丝裂霉素-C的随机相3试验加上疗效D2胃切除术后的短期Doxifluridine或长期Doxifluridine加顺铂（AMC0201）

Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201)

摘要

著录项

相似文献

相关主题

期刊订阅